Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-014963
Filing Date
2012-10-05
Accepted
2012-10-05 16:22:04
Documents
1
Period of Report
2012-10-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3484
  Complete submission text file 0001179110-12-014963.txt   4867
Mailing Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address 249 E. GRAND AVE. SOUTH SAN FRANCISCO CA 94080 650-266-0000
ONYX PHARMACEUTICALS INC (Issuer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ONYX PHARMACEUTICALS, INC. 249 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Torley Helen (Reporting) CIK: 0001528185 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-28298 | Film No.: 121132594